Skip to content
ContactContact

In pharmaceutical manufacturing, few issues are more frustrating than batch‑to‑batch variability. The formulation is unchanged. The recipe is identical. The equipment is the same. Yet blend uniformity results shift, content uniformity drifts, or downstream processing behaves differently from one batch to the next.

This variability is rarely caused by a single failure. More often, it is the result of small, cumulative changes in powder behaviour, process conditions, or equipment utilisation that are not immediately visible but materially affect outcomes.

Understanding why batch‑to‑batch variability occurs is the first step toward controlling it.

Powders Are Not Static Materials

Even when sourced from the same supplier and specification, powders are inherently variable.

Subtle changes in:

It can significantly alter how a powder flows, settles, and blends. Two batches of the same excipient may meet specification yet behave very differently once inside a blender.

This is especially critical in low‑dose formulations, where minor changes in powder behaviour can translate directly into content uniformity risk.

Key point: a consistent recipe does not guarantee consistent powder behaviour.

Fill Volume and Blender Utilisation Drift

One of the most common – and most overlooked – contributors to variability is fill level.

Tumble blenders and V‑shells rely on particle movement and circulation. If the working fill drifts outside the optimal range:

Even small changes in batch size, bulk density, or operator loading practices can shift fill volume enough to affect blend quality.

Key point: the same blender can behave very differently at 40% fill versus 70% fill.

Mixing Time Is Not Always a Fixed Variable

Mixing time is often treated as a constant: “we always blend for X minutes.” In reality, the effective mixing time can vary.

Factors such as:

all influence how quickly a blend reaches homogeneity. A time that worked for one batch may be insufficient – or excessive – for the next.

Key point: fixed time does not equal fixed mixing performance.

Segregation During Transfer, Not Mixing

In many cases, variability is introduced after blending.

Common segregation triggers include:

A blend may leave the blender homogeneous but arrive at the next process step stratified.

Key point: batch variability is often a transfer problem, not a blending problem.

Electrostatics and Environmental Conditions

Environmental factors are rarely identical batch to batch.

Changes in:

can alter electrostatic charging, powder adhesion, and wall build‑up. This can affect both mixing behaviour and discharge consistency, particularly with fine or cohesive powders.

Key point: environmental control plays a bigger role than many processes account for.

Operator Interaction and Process Drift

Even well‑designed processes are influenced by human interaction.

Examples include:

None of these alone may be significant, but together they introduce process drift that shows up as batch‑to‑batch variation.

Key point: consistency in execution is as important as consistency in design.

Scale and Equipment Sensitivity

Equipment that performs well at one scale may be less forgiving at another.

Smaller batch sizes are particularly sensitive to:

As batch sizes change – even within the same blender – variability risk increases unless the process is reassessed.

Key point: scaling down is often harder than scaling up

Legacy Equipment vs Current Expectations

Many pharmaceutical blenders remain mechanically sound after decades of use. However, process expectations have evolved.

What was once acceptable may now fall short due to:

Batch variability can be a signal that legacy equipment is no longer optimally aligned with current process demands.

Variability Is a System Issue, Not a Single Fault

The most important takeaway is this:

“Batch‑to‑batch variability is rarely caused by one isolated factor.

It is usually the result of multiple small influences acting together – powder behaviour, fill level, mixing dynamics, transfer steps, environment, and human interaction.

Reducing variability therefore requires a holistic review of the blending and handling process, not just adjustments to mixing time.

A Practical Way Forward

At Terriva, we are often asked to support pharmaceutical manufacturers before variability becomes a deviation or investigation. This typically involves:

The goal is not to change the recipe – but to ensure the process consistently supports it.

Final Thought

If your batches behave differently despite the same formulation, the process is telling you something. Listening early – and understanding the underlying causes – is the most effective way to protect product quality, compliance, and long‑term reliability.

If you’d like to explore how your current blending and powder handling process may be contributing to batch variability, Terriva supports pharmaceutical manufacturers globally with GMP‑compliant blending and dust‑free transfer solutions designed for consistency, not compromise.

Share This Article facebook linkedin
Close